These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 29278509)
1. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy. Kang Y; Cai Y Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509 [TBL] [Abstract][Full Text] [Related]
2. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation. Marotz CA; Zarrinpar A Yale J Biol Med; 2016 Sep; 89(3):383-388. PubMed ID: 27698622 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT). Lee P; Yacyshyn BR; Yacyshyn MB Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245 [TBL] [Abstract][Full Text] [Related]
4. Future prospect of faecal microbiota transplantation as a potential therapy in asthma. Kang Y; Cai Y Allergol Immunopathol (Madr); 2018; 46(3):307-309. PubMed ID: 28803667 [TBL] [Abstract][Full Text] [Related]
5. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial. Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731 [TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation in metabolic syndrome: History, present and future. de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252 [TBL] [Abstract][Full Text] [Related]
7. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. Staley C; Khoruts A; Sadowsky MJ Arch Med Res; 2017 Nov; 48(8):766-773. PubMed ID: 29183720 [TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials. Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284 [TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity. Carlucci C; Petrof EO; Allen-Vercoe E EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. Kang Y; Cai Y J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829 [TBL] [Abstract][Full Text] [Related]
11. Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review. Zhang Z; Mocanu V; Cai C; Dang J; Slater L; Deehan EC; Walter J; Madsen KL Nutrients; 2019 Sep; 11(10):. PubMed ID: 31557953 [TBL] [Abstract][Full Text] [Related]
12. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018 [TBL] [Abstract][Full Text] [Related]
14. Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases. Cammarota G; Pecere S; Ianiro G; Masucci L; Currò D Dig Dis; 2016; 34(3):279-85. PubMed ID: 27027524 [TBL] [Abstract][Full Text] [Related]
15. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome. Manrique P; Zhu Y; van der Oost J; Herrema H; Nieuwdorp M; de Vos WM; Young M Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33794724 [TBL] [Abstract][Full Text] [Related]
16. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073 [TBL] [Abstract][Full Text] [Related]
17. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. Lippert K; Kedenko L; Antonielli L; Kedenko I; Gemeier C; Leitner M; Kautzky-Willer A; Paulweber B; Hackl E Benef Microbes; 2017 Aug; 8(4):545-556. PubMed ID: 28701081 [TBL] [Abstract][Full Text] [Related]
18. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome]. Halmos T; Suba I Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682 [TBL] [Abstract][Full Text] [Related]
19. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome. van der Vossen EWJ; Bastos D; Stols-Gonçalves D; de Goffau MC; Davids M; Pereira JPB; Li Yim AYF; Henneman P; Netea MG; de Vos WM; de Jonge W; Groen AK; Nieuwdorp M; Levin E Gut Microbes; 2021; 13(1):1993513. PubMed ID: 34747338 [TBL] [Abstract][Full Text] [Related]
20. How to Manipulate the Microbiota: Fecal Microbiota Transplantation. Fuentes S; de Vos WM Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]